Purchase Order 75N93023P01221

Award Date 9/7/23
Potential Completion Date 3/7/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Santa Clara, CA 95050, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order contract, valued at $13,594.30, was awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Cyagen Biomodels LLC, a for-profit biotechnology company located in Santa Clara, California. The contract is for the generation of a TBX3 conditional knockout mouse strain to support biomedical research. No small business set-aside was used for this award. Cyagen Biomodels LLC specializes in...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cyagen Biosciences Inc., a self-certified small disadvantaged business. The $16,950.00 firm-fixed price purchase order is for "CYAGEN BIOSCIENCE DOUBLE KNOCKOUT MOUSE PRODUCTION" services. The contract does not have a set-aside designation and is set to conclude on September 15, 2014. Cyagen Biosciences Inc. is the prime contractor, and no major...
This federal contract award to Cyagen Biomodels LLC, a biotechnology company based in Santa Clara, California, is for the replacement of a previous purchase order from the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The $30,915.00 firm-fixed-price purchase order does not have a set-aside designation. Cyagen Biomodels LLC specializes in providing custom genetic model services to support biomedical research, including the creation of...
The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $121,347 firm fixed price purchase order to Cyagen Biomodels LLC of Santa Clara, California. The contract is for the generation of conditional knock-in and knock-out mouse models to support the agency's research focusing on the development of the mammalian hematopoietic system and study of signal transduction molecules and pathways that regulate T...
This federal contract award is for a delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The prime contractor is Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The award, valued at $7,286.00, is for additional breeding and other services to support gene targeting,...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a firm fixed price purchase order valued at twenty-one thousand two hundred ninety-two dollars and fifty cents ($21,292.50) to Cyagen Biosciences Inc. of Santa Clara, California. The contract is for the delivery of a guaranteed germline package of HUMAN GPR101 E308D mutant knockin mice to the agency. Performance will take place in Santa Clara, California...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $786,726.00 delivery order contract to Medical Science & Computing, LLC to provide genotyping and genetic monitoring services for transgenic mice. The contract has a period of performance from April 25, 2022 through April 24, 2023 and utilizes a time and materials pricing structure. The work will be performed in Bethesda, Maryland to support the Division of Intramural Research's efforts to...
This federal contract award is for the provision of live animals, specifically genetically modified mice, to support biomedical research. The prime contractor, Ozgene PTY LTD, an Australian company, is providing gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to various agencies within the U.S. Department of Health and Human Service's National Institutes of Health (NIH). The contract, with a ceiling value of $5,971.00, is a firm fixed-price...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The contract, valued at $5,940.00, was awarded to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract is for the delivery of MICE, with no set-aside designation. Ozgene PTY LTD, as the...
The National Institutes of Health (NIH), National Institute of Child Health and Human Development (NICHD) awarded a firm-fixed-price purchase order to Cyagen Biomodels LLC, a biotechnology company based in Santa Clara, California, for $43,795.00. The contract is for "Turboknockout Gene Targeting Services" to support NICHD's mammalian hematopoietic system research. NICHD determined that Cyagen Biomodels LLC is the only company capable of providing the required services, which allow...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $17,971.50 firm fixed price purchase order to Cyagen Biomodels LLC for conditional knockout mouse model services (Ambis #2185806). As the prime contractor, Cyagen Biomodels LLC will deliver the requested mouse models from its facility in Santa Clara, California under the terms of this contract over a six-month period concluding in March 2024. The award was made utilizing an existing NIH contract vehicle and will support the agency's research efforts to advance understanding of disease mechanisms and develop new treatments through innovative animal modeling.

Generated 12/15/23, 2:48 AM